EUVIMEDEUVIMED entdecken
Crossref

Forgoing node dissection for desmoplasia-negative hereditary medullary thyroid cancer

Andreas Machens iD, Claudia Bensch, Claudia Wickenhauser iD, Henning Dralle iD, Kerstin Lorenz iD

Endocrine-Related Cancer · 2026

DOI: 10.1530/erc-26-0148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2026. Verfasst von Andreas Machens und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Visceral, Vascular and Endocrine Surgery , Martin Luther University Halle-Wittenberg, Halle (Saale), Germany. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Neuroendocrine, Lymph Node Excision. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinically inapparent node metastases, requiring neck dissection in addition to thyroidectomy, pose a diagnostic challenge in patients with medullary thyroid cancer (MTC). Although desmoplasia negativity has emerged as a powerful marker of node-negative disease, its clinical utility in hereditary MTC remains ill-defined. This cross-sectional investigation employed multivariable logistic regression on, and stratification of clinical variables by, nodal status of 124 RET carriers with MTC who underwent initial total thyroidectomy with at least central neck dissection between 2000 and 2025 at a tertiary center. Unlike tumor size, grade, laterality, index status, and sex, only desmoplasia (>10% vs ≤5%), basal serum calcitonin (>500 pg/mL >> 101–500 pg/mL vs ≤100 pg/mL), and RET category (highest (p.Met918Thr) vs any other) were independently associated with node metastases. In unilateral MTC, desmoplasia ≤5% was always associated with freedom from node metastases (0 of 15 patients), whereas tumor size ≤5 mm and basal serum calcitonin ≤100 pg/mL were associated with node metastases in 4 (18%) of 22 patients and 4 (15%) of 26 patients, respectively. In bilateral MTC, none of the above thresholds were sufficiently discriminatory, suggesting metastatic cross-contamination by the contralateral MTC. In unilateral MTC with desmoplasia ≤5%, node metastases were always absent, regardless of whether basal calcitonin levels were ≤100 (based on 13 patients) or >100 pg/mL (based on 2 patients). This comprehensive proof-of-concept study demonstrates that RET carriers with desmoplasia-negative unilateral MTC may forgo node dissection at specialist centers, similarly to what has been proposed for patients with desmoplasia-negative sporadic MTC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsCarcinoma, NeuroendocrineLymph Node ExcisionHumansFemaleMaleMiddle AgedAdultLymphatic MetastasisCross-Sectional StudiesProto-Oncogene Proteins c-retNeck DissectionThyroidectomyCalcitoninYoung AdultAgedCarcinoma, MedullaryMultiple Endocrine Neoplasia Type 2a

Stichwörter der Autor:innen

desmoplasialymph node metastasismedullary thyroid carcinomamultiple endocrine neoplasia type 2personalized medicineprecision surgery

Substanzen

Proto-Oncogene Proteins c-retCalcitoninRET protein, human

Autor:innen und Institutionen

  • Department of Visceral, Vascular and Endocrine Surgery , Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
  • Department of Pathology, Martin Luther University Halle-Wittenberg , Halle (Saale), Germany.
  • Department of General, Visceral and Transplantation Surgery, Section of Endocrine Surgery, University of Duisburg-Essen , Essen, Germany.

ORCID-Profile: Andreas Machens, Claudia Wickenhauser, Henning Dralle, Kerstin Lorenz

Zitieren

APA

Machens, A., Bensch, C., Wickenhauser, C., Dralle, H., & Lorenz, K. (2026). Forgoing node dissection for desmoplasia-negative hereditary medullary thyroid cancer. Endocrine-Related Cancer. https://doi.org/10.1530/erc-26-0148

Vancouver

Machens A, Bensch C, Wickenhauser C, Dralle H, Lorenz K. Forgoing node dissection for desmoplasia-negative hereditary medullary thyroid cancer. Endocrine-Related Cancer. 2026. doi:10.1530/erc-26-0148

BibTeX
@article{Machens2026,
  author = {Machens, Andreas and Bensch, Claudia and Wickenhauser, Claudia and Dralle, Henning and Lorenz, Kerstin},
  title = {Forgoing node dissection for desmoplasia-negative hereditary medullary thyroid cancer},
  journal = {Endocrine-Related Cancer},
  year = {2026},
  doi = {10.1530/erc-26-0148}
}
Kostenlos starten →